Frailty is a common negative consequence of ageing. Sarcopenia, the syndrome of loss of
muscle mass, quality and strength, is more common in older adults and has been …

Since the discovery that rapamycin, a small molecule inhibitor of the protein kinase mTOR
(mechanistic target of rapamycin), can extend the lifespan of model organisms including …

As we age, there is an age-related loss in skeletal muscle mass and strength, known as
sarcopenia. Sarcopenia results in a decrease in mobility and independence, as well as an …

Sarcopenia is defined as the combined loss of skeletal muscle strength, function, and/or
mass with aging. This degenerative loss of muscle mass is associated with poor quality of …

Menopause is associated with hormonal changes, which could accelerate or lead to
sarcopenia. Functional impairment and physical disability are the major consequences of …

Among the various aspects of health promotion and lifestyle adaptation to the
postmenopausal period, nutritional habits are essential because they concern all women …

Skeletal muscle, which accounts for approximately 40% of total body weight, is one of the
most dynamic and plastic tissues in the human body and plays a vital role in movement …

Background Nutrient acquisition and metabolism pathways are altered in cancer cells to
meet bioenergetic and biosynthetic demands. A major regulator of cellular metabolism and …

Sarcopenia is an aging-induced syndrome characterized by a progressive reduction of
skeletal muscle mass and strength. Increasing evidence has attested that appropriate and …

Aging poses a high risk of lean mass loss, which can be effectively improved through
resistance exercise training (RET), or multicomponent exercise training (MET) as well as …